Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank43
3Y CAGR-7.3%
5Y CAGR-63.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-7.3%/yr
Annual compound
5Y CAGR
-63.7%/yr
Recent acceleration
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 11.00 | -4.0% |
| 2024 | 11.46 | +44.6% |
| 2023 | 7.93 | -42.6% |
| 2022 | 13.80 | -97.9% |
| 2021 | 644.51 | -62.8% |
| 2020 | 1734.31 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |